TONIX PHARMACEUTICALS HOLDING CORP. S-8
Exhibit 107
Calculation of Filing Fee Tables
FORM S-8
(Form Type)
TONIX PHARMACEUTICALS HOLDING CORP.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
|
Title of Securities To Be Registered |
Amount To Be Registered(1) |
Proposed Maximum Offering Price Per Share(2) |
Proposed Maximum Aggregate Offering Price |
Amount of Registration Fee |
||||||||||||
| Common stock, $0.001 par value per share | 1,886,971 | $ | 1.80 | $ | 3,396,548 | $ | 315 | |||||||||
| (1) | Covers 1,793,221 shares of common stock issuable under the Tonix Pharmaceuticals Holding Corp. Amended and Restated 2020 Stock Incentive Plan. In addition, pursuant to Rule 416(c) under the Securities Act of 1933, as amended (the “Securities Act”), and 93,750 shares of common stock issuable under the Tonix Pharmaceuticals Holding Corp. 2022 Employee Stock Purchase Plan. In addition, pursuant to Rule 416(c) under the Securities Act, this registration statement also covers an indeterminate amount of interests to be offered or sold pursuant to the employee benefit plan(s) described herein, as these amounts may be adjusted as a result of stock splits, stock dividends, antidilution provisions, and similar transactions. |
| (2) | Pursuant to Rule 457(c) and Rule 457(h) under the Securities Act, the proposed maximum offering price per share and the proposed maximum aggregate offering price are estimated for the purpose of calculating the amount of the registration fee and are based on the average of the high and low sales price on the NASDAQ Capital Market on June 15, 2022. |